imeik technology development announcement, the company received the "Medical Device Registration Certificate" issued by the National Medical Products Administration on October 9, 2024. The product is named as cross-linked hyaluronic acid sodium gel containing polyethylene glycol gel microspheres for medical use, with a registration number of Guoshui Zhun 20.243 billion, valid from the approval date until September 29, 2029. The product is suitable for adult subcutaneous injection on the bone membrane to improve mild to moderate chin retrusion. The acquisition of the above product enriches the company's product categories and helps enhance the company's core competitiveness.